Analystreport

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) had its price target raised by analysts at Cantor Fitzgerald from $150.00 to $174.00.

Sarepta Therapeutics, Inc.  (SRPT) 
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm Check Earnings Report